Dermatology OTC Medications Market

Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Dermatology OTC Medications Market contains market size and forecasts of Dermatology OTC Medications in global, including the following market information:
Global Dermatology OTC Medications Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dermatology OTC Medications Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Dermatology OTC Medications companies in 2021 (%)
The global Dermatology OTC Medications market was valued at 13150 million in 2021 and is projected to reach US$ 16350 million by 2028, at a CAGR of 3.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
External Use Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermatology OTC Medications include Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, Sun Pharmaceutical, Aurobindo and Galderma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dermatology OTC Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatology OTC Medications Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, by Type, 2021 (%)
External Use
Oral
Global Dermatology OTC Medications Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, by Application, 2021 (%)
Hospital
Drug Store
Other
Global Dermatology OTC Medications Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Dermatology OTC Medications Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatology OTC Medications revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dermatology OTC Medications revenues share in global market, 2021 (%)
Key companies Dermatology OTC Medications sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Dermatology OTC Medications sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui